These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 3102504
1. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. Genton C, Kruithof EK, Schleuning WD. J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504 [Abstract] [Full Text] [Related]
2. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester. Gyetko MR, Webb AC, Sitrin RG. J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763 [Abstract] [Full Text] [Related]
3. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor. Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R. J Cell Physiol; 1989 Jul 15; 140(1):119-30. PubMed ID: 2500450 [Abstract] [Full Text] [Related]
4. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Schuster WA, Medcalf RL, Kruithof EK. Endocrinology; 1993 Oct 15; 133(4):1724-30. PubMed ID: 8404615 [Abstract] [Full Text] [Related]
5. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. Gross TJ, Sitrin RG. J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845 [Abstract] [Full Text] [Related]
6. Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562). Oliver LJ, Keeton M, Wilson EL. Blood; 1989 Sep 01; 74(4):1321-7. PubMed ID: 2504306 [Abstract] [Full Text] [Related]
7. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8]. Niiya K, Sakuragawa N. Nihon Rinsho; 1992 Feb 01; 50(2):325-9. PubMed ID: 1319513 [Abstract] [Full Text] [Related]
8. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells. Rondeau E, Guidet B, Lacave R, Bens M, Sraer J, Nagamine Y, Ardaillou R, Sraer JD. Biochim Biophys Acta; 1990 Nov 12; 1055(2):165-72. PubMed ID: 2122915 [Abstract] [Full Text] [Related]
9. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator. Rehemtulla A, Gates J, Hart DA. Comp Biochem Physiol B; 1987 Nov 12; 88(1):277-83. PubMed ID: 3119281 [Abstract] [Full Text] [Related]
10. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA. Dear AE, Costa M, Medcalf RL. FEBS Lett; 1997 Feb 03; 402(2-3):265-72. PubMed ID: 9037208 [Abstract] [Full Text] [Related]
11. Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. Ye RD, Wun TC, Sadler JE. J Biol Chem; 1988 Apr 05; 263(10):4869-75. PubMed ID: 3127394 [Abstract] [Full Text] [Related]
12. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells. Peraldi MN, Rondeau E, Medcalf RL, Hagège J, Lacave R, Delarue F, Schleuning WD, Sraer JD. Biochim Biophys Acta; 1992 Apr 07; 1134(3):189-96. PubMed ID: 1558843 [Abstract] [Full Text] [Related]
13. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60. Alving BM, Krishnamurti C, Liu YP, Lucas DL, Wright DG. Thromb Res; 1988 Jul 15; 51(2):175-85. PubMed ID: 3142093 [Abstract] [Full Text] [Related]
14. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2. Kole KL, Gyetko MR, Simpson RU, Sitrin RG. Biochem Pharmacol; 1991 Feb 15; 41(4):585-91. PubMed ID: 1900005 [Abstract] [Full Text] [Related]
15. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Antalis TM, Dickinson JL. Eur J Biochem; 1992 Apr 01; 205(1):203-9. PubMed ID: 1555580 [Abstract] [Full Text] [Related]
16. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. Medcalf RL, Van den Berg E, Schleuning WD. J Cell Biol; 1988 Mar 01; 106(3):971-8. PubMed ID: 3126194 [Abstract] [Full Text] [Related]
17. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Schleuning WD, Medcalf RL, Hession C, Rothenbühler R, Shaw A, Kruithof EK. Mol Cell Biol; 1987 Dec 01; 7(12):4564-7. PubMed ID: 3325828 [Abstract] [Full Text] [Related]
18. Identification of urokinase-type plasminogen activator receptor in human endothelial cells and its modulation by phorbol myristate acetate. Matsumoto H, Ueshima S, Fukao H, Mitsui Y, Matsuo O. Cell Struct Funct; 1995 Dec 01; 20(6):429-37. PubMed ID: 8825063 [Abstract] [Full Text] [Related]
19. Urokinase synthesis and binding by glomerular epithelial cells in culture. Rondeau E, Ochi S, Lacave R, He CJ, Medcalf R, Delarue F, Sraer JD. Kidney Int; 1989 Oct 01; 36(4):593-600. PubMed ID: 2554052 [Abstract] [Full Text] [Related]
20. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. Wohlwend A, Belin D, Vassalli JD. J Exp Med; 1987 Feb 01; 165(2):320-39. PubMed ID: 2434595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]